NCT05127564View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Diroximel Fumarate (DRF) in Chinese and Caucasian Adult Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 3, 2021

Primary Completion Date

June 9, 2022

Study Completion Date

June 29, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

Diroximel fumarate

Administered as specified in the treatment arm

Trial Locations (2)

8011

Research Site, Christchurch

Unknown

Research Site, Shatin

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY